Devices descending from K183031
3 later devices reach ETEST Meropenem/Vaborbactam (MEV) (0.004/8-64/8 µg/mL) through their predicates, nearest generation first.
| Generation | Number | Device | Applicant | Decided | Own descendants | Recalls |
|---|---|---|---|---|---|---|
| +1 | K250274 | ETEST Imipenem/Relebactam P. aeruginosa (IRPA) (0.008/4-128/4 µg/mL) | Biomerieux S.A. | 2025 | 0 | — |
| +1 | K232395 | ETEST® Sulbactam/Durlobactam (SUD) (0.004/4-64/4 µg/mL), ETEST® SUD | Biomérieux | 2023 | 0 | — |
| +1 | K191953 | ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL) | Biomerieux S.A. | 2019 | 0 | 2 |